AHA Coding Clinic® for HCPCS - 2018 Issue 4; For Your Information
Another HCPCS code for the reporting of biosimilar products
HCPCS code Q5108, Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg, was recently added to the list of HCPCS codes utilized for the reporting of biosimilar products. This HCPCS code became effective for the reporting of services October 1, 2018. ...
To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.